309 related articles for article (PubMed ID: 36765614)
1. Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment.
Jin R; Hao J; Yu J; Wang P; Sauter ER; Li B
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765614
[TBL] [Abstract][Full Text] [Related]
2. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
Lim AR; Rathmell WK; Rathmell JC
Elife; 2020 May; 9():. PubMed ID: 32367803
[TBL] [Abstract][Full Text] [Related]
3. Lipids for CD8
Wu D; Chen Y
Front Immunol; 2022; 13():1020422. PubMed ID: 36275711
[TBL] [Abstract][Full Text] [Related]
4. Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma.
Liu F; Liu W; Zhou S; Yang C; Tian M; Jia G; Wang H; Zhu B; Feng M; Lu Y; Qiao T; Wang X; Cao W; Wang X; Shi Y; Wu D
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32611686
[TBL] [Abstract][Full Text] [Related]
5. Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression.
Zhang Y; Ertl HC
Front Immunol; 2016; 7():32. PubMed ID: 26904023
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment metabolites directing T cell differentiation and function.
Liu X; Hoft DF; Peng G
Trends Immunol; 2022 Feb; 43(2):132-147. PubMed ID: 34973923
[TBL] [Abstract][Full Text] [Related]
7. The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling.
Bilemjian V; Vlaming MR; Álvarez Freile J; Huls G; De Bruyn M; Bremer E
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804934
[TBL] [Abstract][Full Text] [Related]
8. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.
Ringel AE; Drijvers JM; Baker GJ; Catozzi A; García-Cañaveras JC; Gassaway BM; Miller BC; Juneja VR; Nguyen TH; Joshi S; Yao CH; Yoon H; Sage PT; LaFleur MW; Trombley JD; Jacobson CA; Maliga Z; Gygi SP; Sorger PK; Rabinowitz JD; Sharpe AH; Haigis MC
Cell; 2020 Dec; 183(7):1848-1866.e26. PubMed ID: 33301708
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment.
Liu X; Zhao Y; Wu X; Liu Z; Liu X
Front Oncol; 2022; 12():931104. PubMed ID: 35924168
[TBL] [Abstract][Full Text] [Related]
10. Fatty Acid Oxidation Controls CD8
Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
[TBL] [Abstract][Full Text] [Related]
11. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation.
Beckermann KE; Hongo R; Ye X; Young K; Carbonell K; Healey DCC; Siska PJ; Barone S; Roe CE; Smith CC; Vincent BG; Mason FM; Irish JM; Rathmell WK; Rathmell JC
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814710
[TBL] [Abstract][Full Text] [Related]
12. Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.
Qiao G; Chen M; Mohammadpour H; MacDonald CR; Bucsek MJ; Hylander BL; Barbi JJ; Repasky EA
Cancer Immunol Res; 2021 Jun; 9(6):651-664. PubMed ID: 33762351
[TBL] [Abstract][Full Text] [Related]
13. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid-binding protein 5 limits the generation of Foxp3
Kobayashi S; Wannakul T; Sekino K; Takahashi Y; Kagawa Y; Miyazaki H; Umaru BA; Yang S; Yamamoto Y; Owada Y
Int J Cancer; 2022 Jan; 150(1):152-163. PubMed ID: 34449874
[TBL] [Abstract][Full Text] [Related]
15. Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
Lee MH; Theodoropoulos J; Huuhtanen J; Bhattacharya D; Järvinen P; Tornberg S; Nísen H; Mirtti T; Uski I; Kumari A; Peltonen K; Draghi A; Donia M; Kreutzman A; Mustjoki S
Cancer Res Commun; 2023 Jul; 3(7):1260-1276. PubMed ID: 37484198
[TBL] [Abstract][Full Text] [Related]
16. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
17. The Metabolic Profile of Tumor and Virally Infected Cells Shapes Their Microenvironment Counteracting T Cell Immunity.
Magalhaes I; Yogev O; Mattsson J; Schurich A
Front Immunol; 2019; 10():2309. PubMed ID: 31636636
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma.
Garcia KA; Costa ML; Lacunza E; Martinez ME; Corsico B; Scaglia N
Life Sci; 2022 Jul; 301():120621. PubMed ID: 35545133
[TBL] [Abstract][Full Text] [Related]
19. Manipulating T-cell metabolism to enhance immunotherapy in solid tumor.
Chen C; Wang Z; Ding Y; Qin Y
Front Immunol; 2022; 13():1090429. PubMed ID: 36618408
[TBL] [Abstract][Full Text] [Related]
20. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
